Global Respiratory Syncytial Virus Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2201020198 | Category: Medical Care | Pages: 113 | Format: PDF | Published Date: June 20,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Respiratory Syncytial Virus Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Respiratory Syncytial Virus Diagnostics market size is estimated to be worth US$ 580.7 million in 2021 and is forecast to a readjusted size of USD 843.6 million by 2028 with a CAGR of 5.5% during review period. Hospitals accounting for  % of the Respiratory Syncytial Virus Diagnostics global market in 2021, is projected to value USD   million by 2028, growing at a  % CAGR in next six years. While Direct Fluorescent Antibody Method segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Respiratory Syncytial Virus Diagnostics include Becton Dickinson, Abbott Laboratories, Abbott, Beckman Coulter/Danaher, and Bio-Rad Laboratories, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Respiratory Syncytial Virus Diagnostics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Direct Fluorescent Antibody Method
    Rapid Antigen Diagnostic Tests
    Molecular Diagnostics
    Chromatographic Immunoassay
    Diagnostic Imaging
    Gel Microdroplets
    Flow Cytometry
    Other
Market segment by Application, can be divided into
    Hospitals
    Laboratory
    Clinics
    Homecare
Market segment by players, this report covers
    Becton Dickinson
    Abbott Laboratories
    Abbott
    Beckman Coulter/Danaher
    Bio-Rad Laboratories
    Coris BioConcept
    DiaSorin SPA
    Eiken Chemical
    Elitech
    Fujirebio
    Grifols
    Hoffmann La Roche
    Hologic
    Novartis Diagnostics
    Ortho Clinical Diagnostics
    Roche Diagnostics
    Scienion
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Respiratory Syncytial Virus Diagnostics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Respiratory Syncytial Virus Diagnostics, with revenue, gross margin and global market share of Respiratory Syncytial Virus Diagnostics from 2019 to 2022.
Chapter 3, the Respiratory Syncytial Virus Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Respiratory Syncytial Virus Diagnostics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Respiratory Syncytial Virus Diagnostics research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Respiratory Syncytial Virus Diagnostics
    1.2 Classification of Respiratory Syncytial Virus Diagnostics by Type
        1.2.1 Overview: Global Respiratory Syncytial Virus Diagnostics Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Type in 2021
        1.2.3 Direct Fluorescent Antibody Method
        1.2.4 Rapid Antigen Diagnostic Tests
        1.2.5 Molecular Diagnostics
        1.2.6 Chromatographic Immunoassay
        1.2.7 Diagnostic Imaging
        1.2.8 Gel Microdroplets
        1.2.9 Flow Cytometry
        1.2.10 Other
    1.3 Global Respiratory Syncytial Virus Diagnostics Market by Application
        1.3.1 Overview: Global Respiratory Syncytial Virus Diagnostics Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Laboratory
        1.3.4 Clinics
        1.3.5 Homecare
    1.4 Global Respiratory Syncytial Virus Diagnostics Market Size & Forecast
    1.5 Global Respiratory Syncytial Virus Diagnostics Market Size and Forecast by Region
        1.5.1 Global Respiratory Syncytial Virus Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Respiratory Syncytial Virus Diagnostics Market Size by Region, (2017-2022)
        1.5.3 North America Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2017-2028)
        1.5.4 Europe Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2017-2028)
        1.5.6 South America Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Respiratory Syncytial Virus Diagnostics Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Respiratory Syncytial Virus Diagnostics Market Drivers
        1.6.2 Respiratory Syncytial Virus Diagnostics Market Restraints
        1.6.3 Respiratory Syncytial Virus Diagnostics Trends Analysis
2 Company Profiles
    2.1 Becton Dickinson
        2.1.1 Becton Dickinson Details
        2.1.2 Becton Dickinson Major Business
        2.1.3 Becton Dickinson Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.1.4 Becton Dickinson Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Becton Dickinson Recent Developments and Future Plans
    2.2 Abbott Laboratories
        2.2.1 Abbott Laboratories Details
        2.2.2 Abbott Laboratories Major Business
        2.2.3 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.2.4 Abbott Laboratories Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Abbott Laboratories Recent Developments and Future Plans
    2.3 Abbott
        2.3.1 Abbott Details
        2.3.2 Abbott Major Business
        2.3.3 Abbott Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.3.4 Abbott Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Abbott Recent Developments and Future Plans
    2.4 Beckman Coulter/Danaher
        2.4.1 Beckman Coulter/Danaher Details
        2.4.2 Beckman Coulter/Danaher Major Business
        2.4.3 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.4.4 Beckman Coulter/Danaher Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Beckman Coulter/Danaher Recent Developments and Future Plans
    2.5 Bio-Rad Laboratories
        2.5.1 Bio-Rad Laboratories Details
        2.5.2 Bio-Rad Laboratories Major Business
        2.5.3 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.5.4 Bio-Rad Laboratories Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
    2.6 Coris BioConcept
        2.6.1 Coris BioConcept Details
        2.6.2 Coris BioConcept Major Business
        2.6.3 Coris BioConcept Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.6.4 Coris BioConcept Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Coris BioConcept Recent Developments and Future Plans
    2.7 DiaSorin SPA
        2.7.1 DiaSorin SPA Details
        2.7.2 DiaSorin SPA Major Business
        2.7.3 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.7.4 DiaSorin SPA Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 DiaSorin SPA Recent Developments and Future Plans
    2.8 Eiken Chemical
        2.8.1 Eiken Chemical Details
        2.8.2 Eiken Chemical Major Business
        2.8.3 Eiken Chemical Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.8.4 Eiken Chemical Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Eiken Chemical Recent Developments and Future Plans
    2.9 Elitech
        2.9.1 Elitech Details
        2.9.2 Elitech Major Business
        2.9.3 Elitech Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.9.4 Elitech Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Elitech Recent Developments and Future Plans
    2.10 Fujirebio 
        2.10.1 Fujirebio Details
        2.10.2 Fujirebio Major Business
        2.10.3 Fujirebio Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.10.4 Fujirebio Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Fujirebio Recent Developments and Future Plans
    2.11 Grifols
        2.11.1 Grifols Details
        2.11.2 Grifols Major Business
        2.11.3 Grifols Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.11.4 Grifols Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Grifols Recent Developments and Future Plans
    2.12 Hoffmann La Roche
        2.12.1 Hoffmann La Roche Details
        2.12.2 Hoffmann La Roche Major Business
        2.12.3 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.12.4 Hoffmann La Roche Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Hoffmann La Roche Recent Developments and Future Plans
    2.13 Hologic
        2.13.1 Hologic Details
        2.13.2 Hologic Major Business
        2.13.3 Hologic Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.13.4 Hologic Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Hologic Recent Developments and Future Plans
    2.14 Novartis Diagnostics
        2.14.1 Novartis Diagnostics Details
        2.14.2 Novartis Diagnostics Major Business
        2.14.3 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.14.4 Novartis Diagnostics Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Novartis Diagnostics Recent Developments and Future Plans
    2.15 Ortho Clinical Diagnostics
        2.15.1 Ortho Clinical Diagnostics Details
        2.15.2 Ortho Clinical Diagnostics Major Business
        2.15.3 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.15.4 Ortho Clinical Diagnostics Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Ortho Clinical Diagnostics Recent Developments and Future Plans
    2.16 Roche Diagnostics
        2.16.1 Roche Diagnostics Details
        2.16.2 Roche Diagnostics Major Business
        2.16.3 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.16.4 Roche Diagnostics Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Roche Diagnostics Recent Developments and Future Plans
    2.17 Scienion
        2.17.1 Scienion Details
        2.17.2 Scienion Major Business
        2.17.3 Scienion Respiratory Syncytial Virus Diagnostics Product and Solutions
        2.17.4 Scienion Respiratory Syncytial Virus Diagnostics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Scienion Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Respiratory Syncytial Virus Diagnostics Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Respiratory Syncytial Virus Diagnostics Players Market Share in 2021
        3.2.2 Top 10 Respiratory Syncytial Virus Diagnostics Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Respiratory Syncytial Virus Diagnostics Players Head Office, Products and Services Provided
    3.4 Respiratory Syncytial Virus Diagnostics Mergers & Acquisitions
    3.5 Respiratory Syncytial Virus Diagnostics New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Respiratory Syncytial Virus Diagnostics Revenue and Market Share by Type (2017-2022)
    4.2 Global Respiratory Syncytial Virus Diagnostics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Respiratory Syncytial Virus Diagnostics Revenue Market Share by Application (2017-2022)
    5.2 Global Respiratory Syncytial Virus Diagnostics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Respiratory Syncytial Virus Diagnostics Revenue by Type (2017-2028)
    6.2 North America Respiratory Syncytial Virus Diagnostics Revenue by Application (2017-2028)
    6.3 North America Respiratory Syncytial Virus Diagnostics Market Size by Country
        6.3.1 North America Respiratory Syncytial Virus Diagnostics Revenue by Country (2017-2028)
        6.3.2 United States Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        6.3.3 Canada Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        6.3.4 Mexico Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Respiratory Syncytial Virus Diagnostics Revenue by Type (2017-2028)
    7.2 Europe Respiratory Syncytial Virus Diagnostics Revenue by Application (2017-2028)
    7.3 Europe Respiratory Syncytial Virus Diagnostics Market Size by Country
        7.3.1 Europe Respiratory Syncytial Virus Diagnostics Revenue by Country (2017-2028)
        7.3.2 Germany Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        7.3.3 France Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        7.3.5 Russia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        7.3.6 Italy Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Type (2017-2028)
    8.2 Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Application (2017-2028)
    8.3 Asia-Pacific Respiratory Syncytial Virus Diagnostics Market Size by Region
        8.3.1 Asia-Pacific Respiratory Syncytial Virus Diagnostics Revenue by Region (2017-2028)
        8.3.2 China Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        8.3.3 Japan Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        8.3.4 South Korea Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        8.3.5 India Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        8.3.7 Australia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Respiratory Syncytial Virus Diagnostics Revenue by Type (2017-2028)
    9.2 South America Respiratory Syncytial Virus Diagnostics Revenue by Application (2017-2028)
    9.3 South America Respiratory Syncytial Virus Diagnostics Market Size by Country
        9.3.1 South America Respiratory Syncytial Virus Diagnostics Revenue by Country (2017-2028)
        9.3.2 Brazil Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        9.3.3 Argentina Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Type (2017-2028)
    10.2 Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Application (2017-2028)
    10.3 Middle East & Africa Respiratory Syncytial Virus Diagnostics Market Size by Country
        10.3.1 Middle East & Africa Respiratory Syncytial Virus Diagnostics Revenue by Country (2017-2028)
        10.3.2 Turkey Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
        10.3.4 UAE Respiratory Syncytial Virus Diagnostics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Respiratory Syncytial Virus Diagnostics Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?